AGIOS PHARMACEUTICALS, INC. - COM (AGIO)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
55.9M
Holdings value Q2 2024
$2.41B
Value change Q2 2024
-$113M
Grand Portfolio weight change Q2 2024
0%
Number of holders
202
Number of buys Q2 2024
96
Number of sells Q2 2024
-106
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 33.7K $1.5M +$781K $44.44 2
2024 Q2 55.9M $2.41B -$113M $43.12 204
2024 Q1 59.4M $1.74B +$78.7M $29.24 184
2023 Q4 57.8M $1.29B +$12.1M $22.27 167
2023 Q3 57.2M $1.42B -$15.7M $24.75 144
2023 Q2 57.7M $1.63B +$16.4M $28.32 151
2023 Q1 57.3M $1.32B -$9.99M $22.97 161
2022 Q4 57.7M $1.62B +$45.1M $28.08 157
2022 Q3 56.2M $1.59B -$46.6M $28.28 156
2022 Q2 57.3M $1.27B -$23.6M $22.17 143
2022 Q1 58.3M $1.7B +$17.7M $29.11 145
2021 Q4 57.6M $1.89B -$88.4M $32.87 149
2021 Q3 59.7M $2.76B -$247M $46.15 158
2021 Q2 64.8M $3.57B +$49.7M $55.11 181
2021 Q1 64.2M $3.31B +$56.1M $51.64 170
2020 Q4 63.9M $2.77B -$22.4M $43.33 190
2020 Q3 64.9M $2.27B -$104M $35.00 205
2020 Q2 66.6M $3.56B -$69.6M $53.48 205
2020 Q1 68.4M $2.43B +$7.75M $35.48 188
2019 Q4 68M $3.24B +$335M $47.75 193
2019 Q3 61.1M $1.98B +$34.3M $32.40 180
2019 Q2 60M $2.99B +$152M $49.88 183
2019 Q1 59.6M $4.02B +$162M $67.44 192
2018 Q4 57.4M $2.65B +$50M $46.11 183
2018 Q3 55.6M $4.29B +$92.8M $77.12 201
2018 Q2 54.4M $4.58B -$33.6M $84.23 209
2018 Q1 54.8M $4.48B +$717M $81.78 193
2017 Q4 47M $2.69B +$50.5M $57.17 174
2017 Q3 46.1M $3.07B +$18M $66.75 170
2017 Q2 46.2M $2.37B +$326M $51.45 167
2017 Q1 41M $2.39B +$239M $58.40 154
2016 Q4 38.9M $1.62B +$47.9M $41.73 153
2016 Q3 37.9M $1.99B +$251M $52.82 162
2016 Q2 34.1M $1.42B +$19.3M $41.89 151
2016 Q1 33.8M $1.37B +$17.9M $40.60 150
2015 Q4 33M $2.14B +$96.2M $64.92 143
2015 Q3 31.4M $2.22B +$82.8M $70.59 149
2015 Q2 30.1M $3.35B +$250M $111.14 160
2015 Q1 28M $2.64B -$37M $94.30 150
2014 Q4 27.7M $3.1B +$395M $112.04 145
2014 Q3 24.5M $1.5B +$79.1M $61.35 120
2014 Q2 23.6M $1.08B +$140M $45.82 98
2014 Q1 20.5M $804M +$94M $39.15 73